Identification of novel benzothiopyranones with ester and amide motifs derived from active metabolite as promising leads against Mycobacterium tuberculosis

Eur J Med Chem. 2021 Oct 15:222:113603. doi: 10.1016/j.ejmech.2021.113603. Epub 2021 Jun 5.

Abstract

We reported three distinct series of novel benzothiopyranones, derived from an active metabolite (M-1) of anti-TB agent 6b. These small molecules were evaluated for their biological activities against a range of Mycobacterium tuberculosis (M. tuberculosis) strains. Preliminary druggability evaluation demonstrated that M-1 showed good aqueous solubility and hepatocyte stability. Benzothiopyranones with acyl, sulfonyl and phosphoryl groups exhibited potent in vitro inhibitory activity against M. tuberculosis H37Rv and low cytotoxicity. In particular, compound 3d, containing a benzoate fragment, displayed marked metabolic stability and potent in vitro activity against drug-resistant tuberculosis clinical strains. Further druggability evaluation based on the identified compounds 3d, 4e and 5b is ongoing for the discovery of promising anti-TB agents.

Keywords: Active metabolite; Benzothiopyranones; Drug-resistant tuberculosis; Metabolic stability.

MeSH terms

  • Amides / chemistry
  • Amides / metabolism
  • Amides / pharmacology*
  • Antitubercular Agents / chemistry
  • Antitubercular Agents / metabolism
  • Antitubercular Agents / pharmacology*
  • Benzopyrans / chemistry
  • Benzopyrans / metabolism
  • Benzopyrans / pharmacology*
  • Dose-Response Relationship, Drug
  • Esters / chemistry
  • Esters / metabolism
  • Esters / pharmacology*
  • Microbial Sensitivity Tests
  • Molecular Structure
  • Mycobacterium tuberculosis / drug effects*
  • Structure-Activity Relationship

Substances

  • Amides
  • Antitubercular Agents
  • Benzopyrans
  • Esters